X
18Sep

Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices

On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By: Robinson+Cole Health Law Diagnosis
Source Url: https://www.jdsupra.com/legalnews/government-continues-to-closely-82799/

Related

Littler Lightbulb: What’s New in New Mexico?

New Mexico has been making waves with several noteworthy labor and employment developments. This Lig...

Read More >

Never, ever, ever assume! (or, how a stuck shoe is like a construction project assumption) (law note)

This summer, I had the fortune of taking a trip to Europe. The first place I visited was Amsterdam...

Read More >

Observations on Atlassian’s Proposed Model Term Sheet

Earlier this week, Atlassian published its form acquisition letter of intent under the banner of The...

Read More >

A Shock to the System Opens New Doors

A number of trends in the financial services industry related to consumer behavior have snowballed s...

Read More >

Three Takeaways from the Updated DOJ and SEC FCPA Resource Guide

On July 3, 2020, the U.S. Department of Justice and the Securities and Exchange Commission issued a ...

Read More >

National Security and Investment Bill: a new frontier for scrutiny of investment in the UK

On 11 November 2020 the UK Government published its groundbreaking National Security and Investment ...

Read More >